Mankind Pharma Ltd. (MANKIND): Mankind Pharma Share Price rises 3% on Rs 95,743.85 crore market cap

Published: 21 September 2026 at 9:49:56 AM IST

Mankind Pharma Share Price rose today to Rs 2,387.50, up 3% from the previous close of Rs 2,318. The stock added Rs 69.50 during the session and ended close to the day’s high of Rs 2,389 after opening at Rs 2,303.05. Mankind Pharma Ltd. now carries a market capitalisation of Rs 95,743.85 crore, placing the move in a large listed healthcare business context. The supplied data confirms the price event, while it does not establish a company-specific catalyst. For readers tracking Mankind Pharma Share Price Today, the main facts are the day’s move, the session range and the valuation backdrop. Univest is useful here because it brings together live share price, financial ratios, peer context and company-specific stock news in one place.

The broader relevance of Mankind Pharma Share Price Today is that the stock moved with a relatively modest turnover of Rs 2.87 crore, without any verified operational trigger in the supplied data. That makes the day’s stock news more about the price move itself, and less about a fresh corporate development. Investors following Mankind Pharma Stock News can therefore focus on the company’s current valuation, earnings profile and comparison with healthcare peers rather than assuming a new event-driven reason.

Mankind Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,387.5
Previous Close	Rs 2,318
Today's Move	Rs 69.5 (+3%)
Open	Rs 2,303.05
High	Rs 2,389
Low	Rs 2,302.3
Turnover	Rs 2.87 crore
Market Capitalisation	Rs 95,743.85 crore
Market Cap Category	Large Cap

Mankind Pharma Ltd. (MANKIND) rose to Rs 2,387.5 from the previous close of Rs 2,318, a move of Rs 69.5 or 3%. The stock opened at Rs 2,303.05, reached a high of Rs 2,389, recorded a low of Rs 2,302.3.

Mankind Pharma Share Price moved from the previous close of Rs 2,318 to Rs 2,387.50, a gain of Rs 69.50 or 3%. The stock opened at Rs 2,303.05, touched a low of Rs 2,302.30 and a high of Rs 2,389. The day’s move shows a clear positive session within the supplied range, and the closing price finished very near the session high. For users checking Mankind Pharma Share Price Live or Mankind Pharma Share Price Update, today’s data is straightforward: price rose, market capitalisation remained at Rs 95,743.85 crore and turnover stood at Rs 2.87 crore. Univest records the same-day price rise without assigning a cause that is not present in the data.

Mankind Pharma Ltd. (MANKIND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 95,743.85 crore
P/E Ratio	46.87x
P/B Ratio	5.69x
ROE	12.69%
ROCE	13.24%
EPS	Rs 49.45
Book Value Per Share	Rs 407.39
Dividend Yield	0.04%

Mankind Pharma Ltd. (MANKIND) fundamental metrics show P/E 46.87x, P/B 5.69x, ROE 12.69%, ROCE 13.24%. These figures provide context only and are not a buy or sell signal.

Mankind Pharma Ltd. has a market capitalisation of Rs 95743.85 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 46.87x, P/B at 5.69x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 49.45, book value per share of Rs 407.39, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	46.87x
Benchmark Median P/E	32.87x
Benchmark Average P/E	48.77x
Benchmark P/E Range	3.4x to 683.5x
Company P/B Ratio	5.69x
Benchmark Median P/B	3.08x
Company ROE	12.69%
Benchmark Median ROE	11.7%
Company ROCE	13.24%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 95,743.85 crore
Benchmark Median Market Cap	Rs 701.78 crore

Mankind Pharma Ltd. (MANKIND) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 46.87x, which is above the benchmark median of 32.87x, a difference of +42.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Mankind Pharma Ltd. (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 11.7%, a difference of +8.46%. Mankind Pharma Ltd. (MANKIND) has a ROCE of 13.24%, which is below the benchmark median of 13.46%, a difference of -1.63%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,397.93	36.41	5.09	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,48,664.42	85.01	14.08	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,82,738.23	83.79	20.36	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,012.19	25.48	4.27	19.69	21.39
Cipla Ltd.	CIPLA	1,10,793.75	32.87	3.15	11.83	16

Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 46.87x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Mankind Pharma Ltd. (MANKIND) has a market capitalisation of Rs 95,743.85 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Mankind Pharma

• Mankind Pharma Share Price rose 3% to Rs 2,387.50 from the previous close of Rs 2,318.
• The stock’s session high was Rs 2,389, while the low was Rs 2,302.30.
• Market capitalisation stood at Rs 95,743.85 crore on the day.
• P/E was 46.87 and P/B was 5.69, both above the industry median.
• ROE was 12.69% and ROCE was 13.24%, which keeps Mankind Pharma Stock Analysis relevant for sector comparison.

About Mankind Pharma

Mankind Pharma Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is followed in Indian Stock Market discussions because it is a large listed pharma business with a market cap of Rs 95,743.85 crore and regular coverage in Mankind Pharma Stock News. Its business is associated with pharma products and the broader healthcare category, making Mankind Pharma Share Price relevant to readers tracking sector-wide stock updates.

From a financial analysis perspective, the company’s reported EPS of Rs 49.45, book value of Rs 407.39 and dividend yield of 0.04% give a simple earnings-and-capital base view of the business. Univest presents these data points alongside the share price so readers can connect company overview, valuation and stock performance in one place. The stock also sits within a peer set that includes Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Cipla, Lupin and Dr. Reddy’s Laboratories.

Track Mankind Pharma Share Price on Univest

Use Mankind Pharma Ltd. (MANKIND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Mankind Pharma Share Price on Univest for live price updates, key financial ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers review Mankind Pharma Share Price Today alongside peer comparison, sector context and broader stock market today coverage. For Mankind Pharma Stock Gaining Today, the platform keeps price, valuation and company news in one view.

Frequently Asked Questions

Why did Mankind Pharma Share Price rise today?

Ans. The supplied data confirms that Mankind Pharma Share Price rose 3% to Rs 2,387.50, but it does not establish a company-specific catalyst. The day’s facts are price, range, turnover and market cap.

What is Mankind Pharma Share Price today?

Ans. Mankind Pharma Share Price today is Rs 2,387.50. It moved up Rs 69.50, or 3%, from the previous close of Rs 2,318 and finished near the day’s high of Rs 2,389.

What is Mankind Pharma’s market capitalisation?

Ans. Mankind Pharma’s market capitalisation is Rs 95,743.85 crore. That places it well above the same-industry median and gives context to Mankind Pharma Share Price when compared with other healthcare names.

How is Mankind Pharma valued compared with peers?

Ans. Mankind Pharma trades at a P/E of 46.87 and P/B of 5.69. That is above the industry median on both metrics and below some premium peers such as Divi’s Laboratories and Torrent Pharmaceuticals.

What do Mankind Pharma’s EPS and book value show?

Ans. EPS is Rs 49.45 and book value is Rs 407.39. EPS indicates earnings attributable to each share, while book value shows accounting net worth per share, both useful for Mankind Pharma Stock Analysis.

How does Mankind Pharma compare with the healthcare sector?

Ans. In the supplied same-industry benchmark, Mankind Pharma’s P/E is above the median but below the average. Its ROE is above the median, while ROCE sits slightly below the median, giving mixed sector context.

Where can I track Mankind Pharma Share Price Live?

Ans. You can track Mankind Pharma Share Price Live on Univest, where the stock page brings together current price, ratios, shareholding pattern, 52-week levels and company news in one place for quick reference.